Patients who underwent a sleeve gastrectomy or gastric bypass lost about five times more weight after two years than people who had weekly injections of semaglutide or tirzepatide (the active ingredients in the anti-obesity drugs Wegovy and Zepbound, respectively), researchers reported Tuesday, June 17, at a meeting of the American Society for Metabolic and Bariatric Surgery
*Please refrain from taking with tea, coffee, medicine jelly, etc
The ligand induced BRET is baseline subtracted
Months 4-6: Total loss typically 20-35 pounds, need for new wardrobe, compliments from Nocatee neighbors and friends, continued progress toward goal
Whats the exposure
The Science of Semaglutide Semaglutide and tirzepatide are prescription medications that mimic a naturally occurring hormone in your body that activates the GLP-1 receptor in your brain